Wanbury (BOM:524212) Cyclically Adjusted Revenue per Share: ₹212.73 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524212 Wanbury Ltd BOM:524212
66 GF Score
Price ₹246.50
GF Value ₹250.95
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Wanbury Cyclically Adjusted Revenue per Share?

Wanbury BOM:524212 +1.02% 66 Cyclically Adjusted Revenue per Share is ₹212.73 as of Jun. 2026. GuruFocus rates BOM:524212 with a GF Score™ of 66/100 and a GF Value™ of ₹250.95 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Wanbury's adjusted revenue per share for the three months ended in Jun. 2026 was ₹46.975. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹212.73 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Wanbury's average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-06), Wanbury's current stock price is ₹246.50. Wanbury's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹212.73. Wanbury's Cyclically Adjusted PS Ratio of today is 1.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Wanbury was 1.56. The lowest was 0.85. And the median was 1.22.


Wanbury  (BOM:524212) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Wanbury's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=246.50/212.73
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Wanbury was 1.56. The lowest was 0.85. And the median was 1.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Wanbury Cyclically Adjusted Revenue per Share Related Terms


Wanbury Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Wanbury's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wanbury Cyclically Adjusted Revenue per Share Chart

Wanbury Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 209.52

Wanbury Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.51 208.29 208.84 209.52 212.73

BOM:524212 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbury's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbury Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbury's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Wanbury's Cyclically Adjusted PS Ratio falls into.


BOM:524212
66GF Score
Wanbury Ltd BOM:524212
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wanbury Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Wanbury's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=46.975/167.3573*167.3573
=46.975

Current CPI (Jun. 2026) = 167.3573.

Wanbury Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201206 55.045 79.567 115.780
201303 0.000 85.687 0.000
201306 59.328 88.365 112.364
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 36.142 111.317 54.337
201809 41.854 115.142 60.834
201812 44.330 115.142 64.433
201903 40.880 118.202 57.880
201906 40.037 120.880 55.431
201909 46.112 123.175 62.652
201912 41.036 126.235 54.404
202003 24.937 124.705 33.466
202006 26.894 127.000 35.440
202009 38.627 130.118 49.682
202012 43.807 130.889 56.012
202103 46.002 131.771 58.426
202106 41.566 134.084 51.881
202109 36.235 135.847 44.640
202112 40.022 138.161 48.480
202203 40.712 138.822 49.081
202206 35.834 142.347 42.130
202209 37.612 144.661 43.513
202212 38.385 145.763 44.072
202303 40.243 146.865 45.858
202306 44.620 150.280 49.690
202309 44.150 151.492 48.774
202312 44.333 152.924 48.517
202403 40.467 153.035 44.254
202406 39.178 155.789 42.087
202409 47.039 157.882 49.862
202412 38.358 158.323 40.547
202503 50.779 157.552 53.939
202506 47.780 159.755 50.054
202509 48.290 162.289 49.798
202512 46.491 163.281 47.652
202603 47.543 164.272 48.436
202606 46.975 167.357 46.975

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹212.73 mean?
Wanbury (BOM:524212) has a Cyclically Adjusted Revenue per Share of ₹212.73 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Wanbury and its competitors.
Is Wanbury's Cyclically Adjusted Revenue per Share too high?
Wanbury's current Cyclically Adjusted Revenue per Share is ₹212.73. Overall, Wanbury has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wanbury's Cyclically Adjusted Revenue per Share compare to ZTS?
Wanbury's Cyclically Adjusted Revenue per Share of ₹212.73 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Wanbury and its competitors. Wanbury's current Cyclically Adjusted Revenue per Share is ₹212.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wanbury stock overvalued right now?
Based on GuruFocus' analysis, Wanbury (BOM:524212) is currently considered Fairly Valued. The stock's GF Value™ is ₹250.95, compared to a current price of ₹246.50 — trading 1.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹212.73. Wanbury's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Wanbury (BOM:524212), the current Cyclically Adjusted Revenue per Share is ₹212.73 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wanbury (BOM:524212) Overvalued in 2026?

Based on GuruFocus' analysis, Wanbury stock appears to be undervalued. The current stock price of ₹246.50 is trading 1.8% below its estimated GF Value™ of ₹250.95. GuruFocus considers Wanbury to be Fairly Valued.

Key valuation signals for BOM:524212:

  • Cyclically Adjusted Revenue per Share: ₹212.73
  • GF Value™: ₹250.95 vs. price of ₹246.50 (1.8% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the BOM:524212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wanbury Business Description

Other Exchanges WANBURY:India
Address Sector 30-A, 10th Floor, BSEL Techpark, B Wing, Opposite Vashi Railway Station, Vashi, Navi Mumbai, MH, IND, 400703
Wanbury Ltd is engaged in the business of pharmaceutical and related activities, including research. Some of the company's products include Cpink 50mg tablets, Rabiplus capsules, and Folinine softgels, among others. The company has one segment of activity, namely, Pharmaceuticals and related products. It generates revenue from contracts with customers through the sale of manufactured and traded goods. Geographically, key revenue is generated from outside India.
66GF Score

Get the complete analysis for BOM:524212

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹246.50
Price
₹250.95
GF Value